Moshe C. Ornstein, MD, MA

Articles by Moshe C. Ornstein, MD, MA

Frontline Therapy Options for Advanced RCC and Combining IO and TKI in the First-line Setting in mRCC

March 18th 2022

A summary of frontline treatment options for metastatic renal cell carcinoma and the rationale for the combination of lenvatinib plus pembrolizumab.

Experts Compare Available Regimens for a Patient With Sarcomatoid Features

ByMoshe C. Ornstein, MD, MA,Amir Mortazavi, MD

March 2nd 2021

During a Targeted Oncology Case-Based Peer Perspective virtual event, Amir Mortazavi, MD andMoshe Ornstein, MD, MA discussed available treatment regimen for a patient with clear cell renal cell carcinoma and sarcomatoid features.

Selecting and Sequencing Therapy in Advanced Urothelial Carcinoma: Navigating a Dynamic Landscape

ByMoshe C. Ornstein, MD, MA

February 14th 2018

Cisplatin-based chemotherapy has been and remains the standard of care in advanced urothelial carcinoma, and can provide a cure for a small subset of these patients.